Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Revam Vet
- Development stage
- Unknown
- Lead developer
- Navana Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Revam Vet is a veterinary multivitamin liquid feed premix developed and marketed by Navana Pharmaceuticals. Formulated as an oral solution, it contains a combination of essential vitamins including Vitamin A, Vitamin D3, Vitamin B1, Vitamin B2, Vitamin B6, Nicotinamide, Calcium D-Pantothenate, and Ascorbic Acid (Vitamin C). It is indicated for livestock, poultry, and aquaculture (fish and shrimp) to prevent and treat vitamin deficiency syndromes, improve appetite, boost immunity, enhance growth and production, and reduce stress during transportation.
- Brand names
- Revam Vet
Beyond the preview
Go deeper on Revam Vet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Revam Vet.